Kurzfassung

First-Line Treatment of Postmenopausal Patients with Endocrine Responsive Metastatic Breast Cancer. A Randomized, Multicenter Study Comparing Letrozol Combined with Standard Chemotherapy Vs Letrozol Single Agent